期刊文献+

聚维酮碘擦拭切口预防肥胖孕妇术后脂肪液化300例观察 被引量:5

Prevention of Fat Liquefaction Following Cesarean Section Using Povidone lodine in Obese Pregnant Women:A Clinical Observation of 300 Cases
原文传递
导出
摘要 目的探讨聚维酮碘擦拭腹部切口预防肥胖孕妇剖宫产术后脂肪液化的临床疗效。方法选择肥胖剖宫产病例300例,随机分为聚维酮碘组(A组)、生理盐水组(B组)及对照组(C组),A组患者术中关腹时,待腹直肌前鞘缝合后,用0.5%聚维酮碘液纱布球擦拭皮下脂肪层、皮肤表面,B组用生理盐水,C组常规缝合,不用药液擦拭;各组患者常规围手术期静脉滴注抗菌药物预防感染;观察其产褥期感染率、术后白细胞总数最高值比较及切口愈合情况。结果A组患者产褥期感染率、术后白细胞总数值比较及切口感染率明显低于B组及C组,差异有统计学意义。结论术中应用聚维酮碘擦拭腹部切口皮下脂肪层、皮肤表面,可减少切口脂肪液化及感染的发生。 OBJECTIVE To explore clinical results of fat liquefaction of incision wound following cesarean section for obese pregnant women.METHODS Totally 300 obese pregnant women with cesarean section were randomly divided into three groups: group A,iodine(PVP-Ⅰ) group(using PVP-Ⅰ(0.5%) after suturing the abdominal rectus sheath);group B(normal saline group);group C(control group without any liquid).All patients were preoperatively used antibiotics to control the infection.The rate of puerperal morbidity,white cell count and wound infection were observed.RESULTS All parameters of group A were lower than group B or C.There were significant differences among three groups(P0.05).CONCLUSIONS Using PIP-Ⅰ to incision site for obese pregnant women after cesarean section can prevent fat necrosis and infection.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2009年第24期3375-3376,共2页 Chinese Journal of Nosocomiology
基金 深圳市福田区科技计划项目医疗卫生类(FTSW018)
关键词 剖宫产 切口脂肪液化 切口感染 聚维酮碘 Cesarean section Infection of incision(PIP-Ⅰ) wound Fat liquefaction Povidone iodine
  • 相关文献

参考文献3

二级参考文献11

  • 1李建团,王新杰.微波照射治疗腹部切口脂肪液化20例[J].中国社区医师(医学专业),2004,6(1):35-36. 被引量:5
  • 2汪临奇.腹部切口脂肪液化的诊治[J].中国基层医药,2005,12(10):1429-1429. 被引量:9
  • 3石建国,张大田,李晨光,张春阳.腹部切口脂肪液化的诊治[J].实用医学杂志,2007,23(9):1439-1439. 被引量:30
  • 4Normand MC, Damato EG. Post cesarean infection. J Obstet Gynecol Neonatal Nurs.2001 Nov-Dec,30(6) :642 - 648.
  • 5Marsden W. Choosing caesarean section. The Lancet, London. Nov 11,2000,356(9242):1677 - 1680.
  • 6Killian CA, Graffunder EM, Vinciguerra TJ, Venezia RA. Risk factors for surgical-site infections following cesarean section. Infect Control Hosp Epidemiol 2001,22:613 - 617.
  • 7Guaschino S, De Santo D, De Seta F. New perspectives in antibiotic prophylaxis for obstetric and .gynaecological surgery. J Hosp Infect, 2002,50 SupplA:SI3 - 16.
  • 8Chelmow D, Ruehli MS, Huang E. Prophylactic use of antibiotics for nonlaboring patients undergoing cesarean delivery with intact membranes: a meta-analysis. Am J Obstet Gyneeol,2001,184(4) :656 - 661.
  • 9Myles TD, Gooch J, Santolaya J. Obesity as an independent risk factor for infectious morbidity in patients who undergo cesarean delivery. Obstet Gynecol,2002,100(5 Pt 1):959-964.
  • 10Liabsuetrakul T, hambiganon P, Chongsuvivatwong V, Boonsom K, Wannaro P. Current status of prophylactic use of antimicrobial agents for cesarean section. J Obstet Gynaecol Res.2002,28(5) :262 - 268.

共引文献93

同被引文献43

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部